Novo Nordisk planlægger at forsyne 50.000 huse med overskudsvarme gennem et nyt rørprojekt, der kan revolutionere grøn ...
Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...
Med skjulte lydoptagelser mener Ekstra Bladet nu at kunne trække tæppet væk under lokalt selskab, der systematisk udnytter ...
I Kalundborg Kommune har de så meget overskudsvarme, at de gerne vil sælge ud af den - og dét er de interesserede i i Holbæk.
Novo Nordisk said on Wednesday it would begin selling its weight-loss drug Wegovy at a discounted price of $499 per month to patients paying cash, as it grapples with shifts to the competitive ...
The CEO of <strong>Novo Nordisk</strong> warned of the impact of tariffs on the pharmaceutical industry. Weight-loss drugs, including Ozempic and Wegovy, could cost ...
Novo Nordisk said Wednesday it will sell Wegovy for $499 a month in cash to patients who can’t get the blockbuster weight-loss drug through insurance, a bid to reach consumers who can’t afford ...
Novo Nordisk (NVO) is not concerned by the ongoing US trade war and the 25% tariff set to go into effect for pharmaceutical companies next week. CEO Lars Jørgensen told reporters Thursday ...
Novo Nordisk A/S and Sanofi are facing an investigation in South Africa over concerns about potential anti-competitive practices in the human insulin pen market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback